Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.

Mutlu, Nilgun; Türkeri, Levent N; Yencilek, Faruk; Demir, Aslan; Emerk, Kaya

Mutlu, Nilgun; Türkeri, Levent N; Yencilek, Faruk; Demir, Aslan; Emerk, Kaya.

Affiliation

Mutlu N; Department of Biochemistry, Yeditepe University Hospital, Istanbul, Turkey.

Can J Urol ; 16(2): 4558-67, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19364428

Subject(s)

Immunoassay/methods; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Adult; Aged; Aged, 80 and over; Area Under Curve; Humans; Male; Middle Aged; Prospective Studies; Reproducibility of Results

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Prostatic Neoplasms / Immunoassay / Prostate-Specific Antigen Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Search on Google

XML

PubMed Links